peopleInnovationCareers RarePipelineCollaborationFinanceAdvance treatment Skip to main contentSkip to navigationSkip to search
HNSA   ( ,  %) SEK
Quotes are delayed 15 minutes

Bo Håkansson has passed away

29 Sep 2014, 11:23
Regulatory information
The Hansa Medical founder and chairman Bo Håkansson passed away during Sunday following a motocross accident at his estate, Farstorp, outside Eslöv, Sweden. He was the largest shareholder in Hansa Medical through his company Farstorps Gård AB.

For further information, please contact:

Hansa Medical AB
Emanuel Björne, CEO
Mobile: +46 707 17 54 77

Hansa Medical pursues clinical development and commercialization of innovative pharmaceuticals and diagnostic methods for the benefit of patients with serious and rare inflammatory diseases. The portfolio includes a marketed diagnostic product, a drug candidate in clinical development, and a preclinical research project. Major shareholders are Farstorps Gård AB, and Nexttobe AB. Hansa Medical is listed on NASDAQ OMX First North (HMED) and Remium Nordic AB is the company’s Certified Adviser. The information in this press release is such information that Hansa Medical AB (publ) is obliged to disclose under the Securities Market Act and/or the Financial Instruments Trading Act. The information was made public on September 29, 2014 at 11:03 CET.